National Infrastructure for ATMP Development
Bridging the gap between academic research, health care and industrial development. ATMP Norway provides access to facilities, quality systems and expertise for advanced therapies based on genes, cells and tissues.
What is ATMP Norway?
ATMP Norway is a national collaborative infrastructure supporting the development of advanced therapy medicinal products, including cell-, gene- and tissue-based therapies. Through a single entry point, research groups, hospitals and industry partners can access structured project assessment, process-development expertise, analytical support, quality assurance and guidance toward GMP manufacturing and clinical readiness. By connecting Norway’s leading university hospitals, technology platforms and regulatory expertise, ATMP Norway helps promising discoveries progress from laboratory concept to safe, standardized and development-ready therapies
How it Works
The journey from innovative idea to a standardized treatment pathway.
1. Idea
Conceptualize an advanced therapy project.
2. Application
Submit your proposal through the entry portal.
3. Review
Expert committee assesses feasibility and fit.
4. Support
Access facilities, guidance and technical expertise.
Partners and collaborators
ATMP Norway is built on national collaboration across hospitals, academia, research environments and innovation partners.
Partners
Collaborators
